Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders 
Longeveron Invited to Present at the Benzinga Global Small Cap Conference
Longeveron recently announced positive results from a Phase 1 study of Lomecel-B in Alzheimer's disease, and the completion of two...
REPEAT – World Renowned Physician Joins Core One Labs as Chief Medical Officer
VANCOUVER, British Columbia, May 05, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN:...
Small Pharma Inc. to Commence Trading on the TSX Venture Exchange on May 6, 2021
Successful listing on TSXV advances Small Pharma’s bold vision to revolutionize the treatment of patients with mental health conditions through...
Evoke Pharma to Report First Quarter 2021 Financial Results on May 12, 2021
SOLANA BEACH, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on...
Achilles Therapeutics to present at the BofA Securities 2021 Virtual Healthcare Conference
LONDON, May 05, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell...
AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files for Approval for Use of Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations in Canada and the EU
SAN DIEGO, May 05, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an...
Aeterna Zentaris Reports First Quarter 2021 Financial Results and Provides Pipeline Program Updates
– Q1 2021 marked by solid operational execution with expansion and diversification of pipeline, intellectual property and portfolio of assets...
Sensei Biotherapeutics Appoints Maura Gillison, M.D., Ph.D., and Richard Ulevitch, Ph.D., to its Immuno-Oncology Advisory Board
BOSTON and ROCKVILLE, Md., May 05, 2021 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical-stage immunotherapy company focused...
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company...
BrainsWay Announces Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer
CRESSKILL, N.J. and JERUSALEM, May 05, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
Excision BioTherapeutics Adds Gene Therapy Expert Nicole Paulk, Ph.D., to its Scientific Advisory Board
SAN FRANCISCO, May 05, 2021 (GLOBE NEWSWIRE) -- Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies...
Celularity Enters into Multi-Year Strategic Partnership with Palantir Technologies
Celularity to leverage Palantir’s next generation software and computational capabilities with their deep cellular data set to accelerate research and...
AgraFlora Appoints Fiona Fitzmaurice as its New Chief Financial Officer
Former CFO Amicably Departing the Company to Facilitate the TransitionVANCOUVER, British Columbia, May 05, 2021 (GLOBE NEWSWIRE) -- AgraFlora Organics...
89bio to Present at Upcoming Investor Conferences
SAN FRANCISCO, May 05, 2021 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development...
PMV Pharmaceuticals Announces Participation at the Bank of America Healthcare Conference
CRANBURY, N.J., May 05, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery...
Eyenovia to Report First Quarter 2021 Results on Wednesday, May 12
Company to host an investor conference call and webcast at 4:30pm ET on that dayNEW YORK, May 05, 2021 (GLOBE...
Sientra Receives Innovative Technology Contract from Vizient for AlloX2® Tissue Expander
Contract recognizes products that bring improvements to the health care industrySANTA BARBARA, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Sientra,...
Catalyst Biosciences Announces First Patient Dosed in Pivotal Phase 3 Registration Study of SQ MarzAA in Individuals with Hemophilia A or B with Inhibitors
SOUTH SAN FRANCISCO, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced the dosing of...
Rhythm Pharmaceuticals to Present at BofA Securities 2021 Virtual Health Care Conference
BOSTON, May 05, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the...
CorMedix Inc. to Report First Quarter 2021 Financial Results and Provide a Corporate Update on May 13
BERKELEY HEIGHTS, N.J., May 05, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...